Don’t mistake “posterior ankle impingement syndrome (os trigonum syndrome)” for a chronic Achilles tendon problem — Dr. Moriwaki maps the pathology of deep posterior heel pain on plantarflexion, and what stem cell conditioned media ankle injection can target for posterior synovitis and soft tissue inflammation versus what it cannot change in the underlying bony anatomy2026.08.04

“When I stand on tiptoe or walk downstairs, something deep behind the Achilles tendon aches.” “In ballet, football, or track — the moment I push off with a strong plantarflexion, a sharp pain shoots into the back of my heel.” When this kind of deep posterior pain on ankle plantarflexion persists for more than six months, it is not uncommon for it to be dismissed as simple Achilles tendonitis or a lingering sprain. Behind it, however, may lie posterior ankle impingement syndrome — a mechanical compression of the posterior process of the talus or an accessory os trigonum between the posterior tibial margin and the calcaneus, driving a chronic inflammatory cycle in the posterior capsule and synovium. In this article, Dr. Moriwaki maps the pathology of posterior ankle impingement syndrome, the conditions it must be distinguished from, and the honest boundary between the posterior intra-articular inflammation that stem cell conditioned media ankle injection can target and the underlying bony anatomy it cannot change.

Key points of this article

・Posterior ankle impingement syndrome is a condition in which, on plantarflexion, the posterior process of the talus or an os trigonum is compressed between the posterior tibial margin and the calcaneus, driving chronic inflammation in the posterior capsule, synovium, and flexor hallucis longus tendon sheath.

・It differs subtly from Achilles tendinopathy, chronic ankle sprain sequelae, and flexor hallucis longus tenosynovitis in the site of pain and the provoking movements — misclassification pulls treatment in the wrong direction.

・What stem cell conditioned media ankle injection can target is suppression of the posterior synovial inflammatory cycle and improvement of the peri-articular soft tissue repair environment; it is not a treatment that changes the bony anatomy of the os trigonum or the posterior talar process itself.

・Active infection, end-stage bony destruction, and the acute post-trauma period are outside its indications; imaging assessment, conservative care, and activity modification take priority as the first steps.

What posterior ankle impingement syndrome actually is

Posterior ankle impingement syndrome is a condition in which, on forced plantarflexion of the ankle, the posterior process of the talus or an accessory os trigonum is compressed between the posterior tibial margin and the superoposterior calcaneus, causing chronic inflammation in the surrounding posterior capsule, synovium, and flexor hallucis longus tendon sheath. It is common in sports that require repeated strong plantarflexion — ballet pointe work, instep kicking in football, track push-off, and downhill running — and the risk rises further in individuals with a congenital os trigonum, said to be present in roughly 3–15% of adults.

The inflammatory chain behind posterior impingement

With every plantarflexion, the impingement of the os trigonum or posterior talar process delivers repeated micro-injury to the posterior capsule and synovium. At the site of injury, pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 are released, driving synovitis and joint effusion. Once this becomes chronic, the posterior capsule undergoes fibrosis and thickening, the surrounding fat tissue scars down, and both range-of-motion restriction and persistent pain become locked in. Because the flexor hallucis longus tendon runs along the medial side of the os trigonum, tenosynovitis (flexor hallucis longus tendinitis) frequently coexists, and this can appear clinically as pain that radiates all the way into the base of the big toe.

Differentiating from Achilles tendinopathy and sprain sequelae decides the direction of treatment

In posterior ankle impingement syndrome, pain is characteristically located “slightly in front of and deep to the Achilles tendon,” which is different from tendinopathy, where pinching the tendon body itself is painful. On examination, the Posterior Impingement Test — passive forced plantarflexion reproducing sharp deep posterior pain — is positive; a lateral plain radiograph, CT, and MRI to evaluate the presence of an os trigonum, the morphology of the posterior talar process, and posterior capsular thickening or bone marrow edema are the starting point of treatment design. For general information on joint disorders, please also refer to the Japanese Orthopaedic Association.

Conditions easily confused

・Achilles tendinosis: centered on degeneration and thickening of the tendon body, with morning-first-step pain and pain at the start of activity.

・Chronic ankle sprain sequelae: chronic injury of the lateral ligaments (anterior talofibular ligament, etc.), presenting mainly with instability and tenderness around the lateral malleolus.

・Flexor hallucis longus tenosynovitis: often coexists with an os trigonum and is distinguished by resisted plantarflexion pain of the great toe.

・Subtalar arthritis: deep hindfoot pain more on inversion/eversion than on plantarflexion.

What stem cell conditioned media ankle injection can and cannot target

When conservative care (activity modification, icing, NSAIDs, physical therapy) has yielded little improvement and repeated local steroid injection is not ideal, stem cell conditioned media ankle injection is considered as an option that “intervenes directly on the posterior intra-articular and peri-articular inflammatory environment” of posterior ankle impingement syndrome. The TGF-β, IGF-1, HGF, and various anti-inflammatory cytokines in the conditioned media can be expected to calm the inflammatory cascade of a chronic synovitis and to improve the repair environment of the posterior capsule and fat pad. Delivering the media precisely into the posterior joint space and around the flexor hallucis longus tendon sheath under ultrasound guidance, via either a posterolateral or posteromedial approach, raises the rate of delivery to the target tissue.

What it cannot target — drawing the honest line

On the other hand, there are things a stem cell conditioned media ankle injection cannot change. The bony anatomy of the os trigonum or the posterior talar process itself, an established bony prominence, or a bony block to range of motion are not going to be absorbed or shrunk by an injection. In situations where repeated strong impingement is unavoidable at the competitive level — ballet being a clear example — quieting the inflammation with an injection does not reliably prevent recurrence, so activity modification and, in cases where symptoms persist, running the plan in parallel with surgical options such as arthroscopic os trigonum excision is a realistic path. For more, see also the AVAN TOKYO Ginza page on stem cell conditioned media joint injection. Response varies between individuals, and any recommendation is made only after carefully judging indication and limits.

Frequently asked questions

Q. Does posterior ankle impingement syndrome resolve on its own?

In mild cases where the provoking movements can be reduced, a few months of activity modification and physical therapy sometimes settle the symptoms. However, in athletes for whom repeated plantarflexion loading is unavoidable, and in cases where an os trigonum is clearly present, chronicity is common and long-term stabilization on conservative care alone tends to be difficult. Deep posterior pain that persists beyond six months warrants an imaging assessment.

Q. How many stem cell conditioned media ankle injections are needed?

It depends on symptom severity and imaging findings, but a common design is 2–3 sessions at 2–4 week intervals during a loading phase, followed by response assessment and a decision on a maintenance phase. Increasing the number of sessions does not automatically translate into proportional benefit; when the response is limited, judgment is required to switch to continuation, modification, or orthopedic re-evaluation.

Q. How does it differ from a steroid injection?

A steroid injection has powerful anti-inflammatory action and is excellent for short-term pain relief, but repeated use carries risks of soft tissue atrophy and tendon weakening. Stem cell conditioned media takes an approach that seeks both “inflammation suppression” and “preparation of the tissue repair environment” — a different orientation. Rather than one being superior, using each according to disease stage and objective is the realistic mindset.

Q. When can I resume sports after the injection?

As a principle, on the day of the injection avoid intense plantarflexion loading and jumping movements, and from the next day gradually resume load while watching the pain course. The timing of return to competition varies with baseline severity and the content of training; a forced early return is a common cause of relapse. Please decide with your treating physician, sharing progress step by step.

Q. Who is it not suited for?

It is off-label or requires great caution in cases of active infection, an acute post-trauma period where fracture or ligament rupture is suspected, cases where the true main cause is a pathology other than posterior impingement, or poorly controlled systemic disease. An accurate diagnosis and imaging assessment come first.

──────────────

[Supervised by] Shin Moriwaki, MD (Supervising Physician)

Member, Japanese Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG Certificate (US Medical Licensure Qualification)

──────────────

📍AVAN TOKYO Ginza Regenerative Medicine

AVAN TOKYO Ginza Regenerative Medicine

English / 中文 / Tiếng Việt available.

Inquiries welcome via DM / LINE / Website / Phone.